IBDEI0WX ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15180,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15180,1,3,0)
 ;;=3^Secondary Malig Neop of Small Intestine
 ;;^UTILITY(U,$J,358.3,15180,1,4,0)
 ;;=4^C78.4
 ;;^UTILITY(U,$J,358.3,15180,2)
 ;;=^5001338
 ;;^UTILITY(U,$J,358.3,15181,0)
 ;;=C44.500^^85^810^12
 ;;^UTILITY(U,$J,358.3,15181,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15181,1,3,0)
 ;;=3^Malig Neop Anal Skin
 ;;^UTILITY(U,$J,358.3,15181,1,4,0)
 ;;=4^C44.500
 ;;^UTILITY(U,$J,358.3,15181,2)
 ;;=^5001051
 ;;^UTILITY(U,$J,358.3,15182,0)
 ;;=C44.509^^85^810^15
 ;;^UTILITY(U,$J,358.3,15182,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15182,1,3,0)
 ;;=3^Malig Neop of Skin of Trunk NEC
 ;;^UTILITY(U,$J,358.3,15182,1,4,0)
 ;;=4^C44.509
 ;;^UTILITY(U,$J,358.3,15182,2)
 ;;=^5001053
 ;;^UTILITY(U,$J,358.3,15183,0)
 ;;=D25.9^^85^810^11
 ;;^UTILITY(U,$J,358.3,15183,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15183,1,3,0)
 ;;=3^Leiomyoma of Uterus,Unspec
 ;;^UTILITY(U,$J,358.3,15183,1,4,0)
 ;;=4^D25.9
 ;;^UTILITY(U,$J,358.3,15183,2)
 ;;=^5002081
 ;;^UTILITY(U,$J,358.3,15184,0)
 ;;=N39.3^^85^810^20
 ;;^UTILITY(U,$J,358.3,15184,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15184,1,3,0)
 ;;=3^Stress Incontinence
 ;;^UTILITY(U,$J,358.3,15184,1,4,0)
 ;;=4^N39.3
 ;;^UTILITY(U,$J,358.3,15184,2)
 ;;=^5015679
 ;;^UTILITY(U,$J,358.3,15185,0)
 ;;=N76.0^^85^810^3
 ;;^UTILITY(U,$J,358.3,15185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15185,1,3,0)
 ;;=3^Acute Vaginitis
 ;;^UTILITY(U,$J,358.3,15185,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,15185,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,15186,0)
 ;;=N76.1^^85^810^21
 ;;^UTILITY(U,$J,358.3,15186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15186,1,3,0)
 ;;=3^Subacute/Chronic Vaginitis
 ;;^UTILITY(U,$J,358.3,15186,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,15186,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,15187,0)
 ;;=N76.2^^85^810^4
 ;;^UTILITY(U,$J,358.3,15187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15187,1,3,0)
 ;;=3^Acute Vulvitis
 ;;^UTILITY(U,$J,358.3,15187,1,4,0)
 ;;=4^N76.2
 ;;^UTILITY(U,$J,358.3,15187,2)
 ;;=^5015828
 ;;^UTILITY(U,$J,358.3,15188,0)
 ;;=N76.3^^85^810^22
 ;;^UTILITY(U,$J,358.3,15188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15188,1,3,0)
 ;;=3^Subacute/Chronic Vulvitis
 ;;^UTILITY(U,$J,358.3,15188,1,4,0)
 ;;=4^N76.3
 ;;^UTILITY(U,$J,358.3,15188,2)
 ;;=^5015829
 ;;^UTILITY(U,$J,358.3,15189,0)
 ;;=N80.9^^85^810^6
 ;;^UTILITY(U,$J,358.3,15189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15189,1,3,0)
 ;;=3^Endometriosis,Unspec
 ;;^UTILITY(U,$J,358.3,15189,1,4,0)
 ;;=4^N80.9
 ;;^UTILITY(U,$J,358.3,15189,2)
 ;;=^5015837
 ;;^UTILITY(U,$J,358.3,15190,0)
 ;;=N81.5^^85^810^23
 ;;^UTILITY(U,$J,358.3,15190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15190,1,3,0)
 ;;=3^Vaginal Enterocele
 ;;^UTILITY(U,$J,358.3,15190,1,4,0)
 ;;=4^N81.5
 ;;^UTILITY(U,$J,358.3,15190,2)
 ;;=^5015842
 ;;^UTILITY(U,$J,358.3,15191,0)
 ;;=N81.9^^85^810^8
 ;;^UTILITY(U,$J,358.3,15191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15191,1,3,0)
 ;;=3^Female Genital Prolapse,Unspec
 ;;^UTILITY(U,$J,358.3,15191,1,4,0)
 ;;=4^N81.9
 ;;^UTILITY(U,$J,358.3,15191,2)
 ;;=^5015845
 ;;^UTILITY(U,$J,358.3,15192,0)
 ;;=N89.7^^85^810^9
 ;;^UTILITY(U,$J,358.3,15192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15192,1,3,0)
 ;;=3^Hematocolpos
 ;;^UTILITY(U,$J,358.3,15192,1,4,0)
 ;;=4^N89.7
 ;;^UTILITY(U,$J,358.3,15192,2)
 ;;=^5015889
 ;;^UTILITY(U,$J,358.3,15193,0)
 ;;=N92.0^^85^810^7
 ;;^UTILITY(U,$J,358.3,15193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15193,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Regular Cycle
